Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multi...
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
About this item
Full title
Author / Creator
Epperla, Narendranath , Zhao, Qiuhong , Chowdhury, Sayan Mullick , Shea, Lauren , Moyo, Tamara K. , Reddy, Nishitha , Sheets, Julia , Weiner, David M. , Geethakumari, Praveen Ramakrishnan , Kandarpa, Malathi , Bruno, Ximena Jordan , Thomas, Colin , Churnetski, Michael C. , Hsu, Andrew , Zurbriggen, Luke , Tan, Cherie , Lindsey, Kathryn , Maakaron, Joseph , Caimi, Paolo F. , Torka, Pallawi , Bello, Celeste , Ayyappan, Sabarish , Karmali, Reem , Kim, Seo-Hyun , Kress, Anna , Kothari, Shalin , Sawalha, Yazeed , Christian, Beth , David, Kevin A. , Greenwell, Irl Brian , Janakiram, Murali , Kenkre, Vaishalee P. , Olszewski, Adam J. , Cohen, Jonathon B. , Palmisiano, Neil , Umyarova, Elvira , Wilcox, Ryan A. , Awan, Farrukh T. , Alderuccio, Juan Pablo , Barta, Stefan K. , Grover, Natalie S. , Ghosh, Nilanjan , Bartlett, Nancy L. , Herrera, Alex F. and Shouse, Geoffrey
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Ibrutinib is effective in the treatment of relapsed/refractory (R/R) marginal zone lymphoma (MZL) with an overall response rate (ORR) of 48%. However, factors associated with response (or lack thereof) to ibrutinib in R/R MZL in clinical practice are largely unknown. To answer this question, we performed a multicenter (25 US centers) cohort study a...
Alternative Titles
Full title
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Authors, Artists and Contributors
Author / Creator
Zhao, Qiuhong
Chowdhury, Sayan Mullick
Shea, Lauren
Moyo, Tamara K.
Reddy, Nishitha
Sheets, Julia
Weiner, David M.
Geethakumari, Praveen Ramakrishnan
Kandarpa, Malathi
Bruno, Ximena Jordan
Thomas, Colin
Churnetski, Michael C.
Hsu, Andrew
Zurbriggen, Luke
Tan, Cherie
Lindsey, Kathryn
Maakaron, Joseph
Caimi, Paolo F.
Torka, Pallawi
Bello, Celeste
Ayyappan, Sabarish
Karmali, Reem
Kim, Seo-Hyun
Kress, Anna
Kothari, Shalin
Sawalha, Yazeed
Christian, Beth
David, Kevin A.
Greenwell, Irl Brian
Janakiram, Murali
Kenkre, Vaishalee P.
Olszewski, Adam J.
Cohen, Jonathon B.
Palmisiano, Neil
Umyarova, Elvira
Wilcox, Ryan A.
Awan, Farrukh T.
Alderuccio, Juan Pablo
Barta, Stefan K.
Grover, Natalie S.
Ghosh, Nilanjan
Bartlett, Nancy L.
Herrera, Alex F.
Shouse, Geoffrey
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_742e9377f2884da1b8eeb0b6ff560e57
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_742e9377f2884da1b8eeb0b6ff560e57
Other Identifiers
ISSN
1756-8722
E-ISSN
1756-8722
DOI
10.1186/s13045-022-01316-1
